Accutane Class Action
Kim Spencer McPhee is working with a consortium of firms across Canada on a claim Claim alleges tha Hoffmann-La Roche, Ltd. McPhee at [email protected].
Kim Spencer McPhee is working with a consortium of firms across Canada to consolidate class actions started in various provinces against Hoffmann-La Roche Ltd Hoffmann-La Roche Limitee, F. AG, Roche Holding Ltd., and Hoffmann-La Roche Inc. (collectively, "Hoffmann-La Roche") seeking damages as a result of Hoffmann-La Roche's development, manufacture and sale of Accutane. Accutane was recommended a
Update: On February 9, 2021, the Ontario Superior Court of Justice dismissed the action on consent of the parties. The dismissal followed an evolution in the science since the action commenced that gave rise to considerable uncertainty regarding a causal link between Accutane use and IBD. This in turn also led to the dismissal of Accutane-related litigation in the United States. To read the Court’s decision, please click file:///C:/Users/dbj/Downloads/Patkus-v-Hoffman-discontinuance-Reasons-for-Decision%20(1).pdf. To see the order, please click fil:///C:/Users/dbj/Downloads/Patkus-v-Hoffman-discontinuance-order.pdf .
**Please note that dismissal of this proposed class proceeding may impact the limitation period applicable to any potential claims related to Accutane. Please seek legal advice immediately if you are thinking of starting an action.**
Click here to claim your Sponsored Listing.
Category
Contact the practice
Telephone
Address
79 Wellington Street West, Suite 2100, PO Box 139
Toronto, ON
M5K1H1